ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05033	Nicotine addiction	22/413	56/7206	9.76095778623e-14
ko04360	Axon guidance	42/413	233/7206	1.52816810596e-11
ko04724	Glutamatergic synapse	31/413	152/7206	3.40152151627e-10
ko04728	Dopaminergic synapse	34/413	185/7206	8.68987403159e-10
ko05032	Morphine addiction	25/413	110/7206	1.73787177802e-09
ko04723	Retrograde endocannabinoid signaling	31/413	175/7206	1.24453710286e-08
ko04010	MAPK signaling pathway	45/413	321/7206	1.74131209148e-08
ko04721	Synaptic vesicle cycle	19/413	80/7206	7.63382245163e-08
ko04727	GABAergic synapse	22/413	110/7206	1.93060290095e-07
ko04713	Circadian entrainment	21/413	136/7206	2.69266455328e-05
ko04024	cAMP signaling pathway	34/413	279/7206	2.95293387015e-05
ko04930	Type II diabetes mellitus	12/413	54/7206	4.0681550849e-05
ko00604	Glycosphingolipid biosynthesis - ganglio series	6/413	14/7206	6.92133830694e-05
ko04514	Cell adhesion molecules (CAMs)	19/413	130/7206	0.000138400184824
ko04144	Endocytosis	36/413	342/7206	0.000310984077158
ko05210	Colorectal cancer	14/413	86/7206	0.000337450617383
ko04725	Cholinergic synapse	21/413	160/7206	0.000364804788191
ko04391	Hippo signaling pathway - fly	14/413	90/7206	0.000544934413369
ko04911	Insulin secretion	16/413	117/7206	0.000970946515311
ko03013	RNA transport	1/413	166/7206	0.00104784371567
ko04390	Hippo signaling pathway	22/413	188/7206	0.00121732213979
ko04261	Adrenergic signaling in cardiomyocytes	23/413	205/7206	0.001892752327
ko04921	Oxytocin signaling pathway	23/413	209/7206	0.00223420683614
ko00515	Mannose type O-glycan biosynthesis	6/413	25/7206	0.00238113123143
ko03040	Spliceosome	1/413	145/7206	0.00326579364809
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	11/413	79/7206	0.00508713885199
ko05203	Viral carcinogenesis	6/413	277/7206	0.00542269853318
ko05031	Amphetamine addiction	12/413	91/7206	0.00548192944549
ko04071	Sphingolipid signaling pathway	18/413	162/7206	0.00580542335668
ko04742	Taste transduction	9/413	61/7206	0.00744600616345
ko04726	Serotonergic synapse	16/413	137/7206	0.00769748366441
ko04080	Neuroactive ligand-receptor interaction	37/413	423/7206	0.0092552904515
ko00190	Oxidative phosphorylation	1/413	127/7206	0.0104261542581
ko05142	Chagas disease (American trypanosomiasis)	15/413	130/7206	0.0111428933002
ko04072	Phospholipase D signaling pathway	20/413	197/7206	0.0118481744162
ko05322	Systemic lupus erythematosus	2/413	151/7206	0.0122307046628
ko04014	Ras signaling pathway	26/413	279/7206	0.0122626383713
ko05231	Choline metabolism in cancer	15/413	134/7206	0.0126506743274
ko04260	Cardiac muscle contraction	12/413	98/7206	0.0128019062014
ko04730	Long-term depression	10/413	78/7206	0.0130648879764
ko05410	Hypertrophic cardiomyopathy (HCM)	12/413	100/7206	0.014113184734
ko04917	Prolactin signaling pathway	11/413	87/7206	0.016176444454
ko04550	Signaling pathways regulating pluripotency of stem cells	17/413	165/7206	0.0165812466572
ko00510	N-Glycan biosynthesis	7/413	50/7206	0.0228010873642
ko05012	Parkinson's disease	3/413	155/7206	0.0351211691392
ko04920	Adipocytokine signaling pathway	10/413	89/7206	0.0354006449219
ko05030	Cocaine addiction	9/413	73/7206	0.0360026708703
ko05414	Dilated cardiomyopathy	12/413	112/7206	0.0362860005944
ko05205	Proteoglycans in cancer	8/413	271/7206	0.0447882862225
ko04670	Leukocyte transendothelial migration	3/413	151/7206	0.0489087646192